TGR5 Receptor Agonist,
1197300-24-5,
TGR5,
CHEMBL575966,
3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-dimethylisoxazole-4-carboxamide,
4-Isoxazolecarboxamide, 3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-dimethyl-,
3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-dimethyl-4-Isoxazolecarboxamide,
3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-dimethyl-1,2-oxazole-4-carboxamide,
CCDC,
CCDC(TGR5-Receptor-Agonist),
SCHEMBL18065752,
AOB2659,
EX-A276,
BCP08750,
BDBM50414954,
MFCD17169972,
ZINC43208218,
AKOS026750223,
CS-2030,
NCGC00371150-04,
AK314861,
BC600398,
HY-14229,
QC-11404,
AB0098427,
DB-061648,
FT-0700111,
A13732,
J-690056,
4-Isoxazolecarboxamide,3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-dimethyl-,
3-?(2-?Chlorophenyl)?-?N-?(4-?chlorophenyl)?-?N,?5-?dimethyl-?4-?isoxazolecarboxamide,
ACN-029588,
2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo[4,3-c]pyridine-3,6(2h,5h)-dione,